CMS seeks feedback on insurance exchange apps

The Centers for Medicare & Medicaid Services (CMS) is seeking public comment on the new single application for health insurance and the Small Business Health Options Program (SHOP) applications in preparation for the launch of a new Health Insurance Marketplace in fall 2014. Model applications and documentation for individuals and SHOP are now available for public comment via the Paperwork Reduction Act (PRA).

The individual application is a single point of entry to purchase private insurance on the Marketplace and assess eligibility for assistance including Medicaid, Children’s Health Insurance Program (CHIP) and the Advanced Payment of Tax Credits. People are asked to review the paper and online applications. To demonstrate how users may interact dynamically with the online application, CMS has posted two videos of the application being completed. One follows a family of three and the other an individual.

SHOP applications for both employers and employees are posted in separate paperwork reduction act packages.

The CMS site with all the PRA packages can be found under the following titles and numbers:

Individual Application

  • Data Collection to Support Eligibility Determinations for Insurance Affordability Programs and Enrollment through Affordable Insurance Exchanges, Medicaid and CHIP Agencies (CMS-10440)

SHOP Employer

  • Data Collection to Support Eligibility Determinations and Enrollment for Small Businesses in SHOP (CMS-10439)

SHOP Employee
• Data Collection to Support Eligibility Determinations and Enrollment for Employees in SHOP (CMS-10438)

 

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.